STREAM-2: Half-Dose Tenecteplase vs Primary PCI in Older Patients with STEMI?
RebelEM
SEPTEMBER 28, 2023
The STREAM-1 trial found that for [2] patients with STEMI presenting within 3 hours of symptom onset and unable to attain PCI within 1 hour of first medical contact, a pharmaco-invasive strategy resulted in similar rates of death, shock, heart failure, or reinfarction compared to primary PCI. Primary PCI: 95.7% Primary PCI: 95.7%
Let's personalize your content